Walleye Capital LLC Sage Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $29,624 - $50,119	2,800 New	2,800 $30,000
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $220,590 - $287,154	12,900 Added 176.71%	20,200 $437,000
Q3 2023 Nov 14, 2023	SELL	$16.75 - $48.98 $85,425 - $249,797	-5,100 Reduced 41.13%	7,300 $150,000
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $504,060 - $738,296	12,400 New	12,400 $583,000
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $77,280 - $104,664	-2,400 Reduced 42.86%	3,200 $122,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $180,768 - $242,312	5,600 New	5,600 $219,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $1.25 Million - $3.22 Million	-20,800 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $2.92 Million - $3.95 Million	20,800 New	20,800 $2.92 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $415M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.